Research roundup

Debbie Rigby rounds up the latest in research news Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes This Korean population based cohort study suggests that SGLT-2 inhibitors might prevent dementia, providing greater benefits with longer treatment (more than 2 years). The incidence rates